What AI says about Larimar Therapeutics

Larimar Therapeutics is a clinical-stage biotechnology company developing treatments for complex rare diseases. Its lead product candidate, nomlabofusp, is being evaluated in a Phase 2 clinical program for Friedreich's ataxia, a rare genetic disease.